CT
Corcept Therapeutics Incorporated
🇺🇸XNAS.CORTUnited StatesHealthcare
$110.56USDdown -1.24 (-1.11%)OpenEnd of day3:24 PM
Price$110.56-1.24 (-1.11%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US2183521028
- CUSIP
- 218352102
Company
- Employees
- 730
- Headquarters
- Redwood City, United States
- Website
- https://www.corcept.com
- CEO
- Dr. Joseph K. Belanoff M.D.
Market
- Shares outstanding
- 108.1M
- Market cap
- $11.95B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $11.95B
- EPS LTM
- $0.46
- P/E LTM
- 187.51
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $830.81M+16.02%up year on year
- Net income
- $54.9M-58.66%down year on year
- Gross margin
- 98.3%-0.07%down year on year
- Free cash flow
- $106.92M-40.69%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.